Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease

Adalimumab (ADA) trough level and anti-ADA antibody (AAA) positivity influence mucosal healing and loss of response in patients with inflammatory bowel disease (IBD). In this study, we clarified the correlation between ADA monitoring, including non-trough level, and real-world IBD clinical outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Masaichi, Sugimoto, Ken, Ikeya, Kentaro, Takano, Ryosuke, Matsuura, Ai, Miyazu, Takahiro, Ishida, Natsuki, Tamura, Satoshi, Tani, Shinya, Yamade, Mihoko, Hamaya, Yasushi, Iwaizumi, Moriya, Osawa, Satoshi, Furuta, Takahisa, Hanai, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270420/
https://www.ncbi.nlm.nih.gov/pubmed/34242369
http://dx.doi.org/10.1371/journal.pone.0254548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270420/
https://www.ncbi.nlm.nih.gov/pubmed/34242369
http://dx.doi.org/10.1371/journal.pone.0254548

Ejemplares similares